Annual EBITDA
$2.17B$265.00M+13.89%
Summary
- Current Value
- As of today, DGX annual EBITDA is $2.17B, up +13.89% on
- Historical Performance
- DGX annual EBITDA is up +5.54% over the past 3 years, down -11.88% over the past 5 years
- All-Time High Comparison
- DGX annual EBITDA is currently -23.81% below its historical high of $2.85B set on
- 3-Year Low Comparison
- DGX annual EBITDA is +21.40% above its 3-year low of $1.79B reached on
- Sector Comparison
- DGX annual EBITDA is higher than 95.62% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $2.17B | +13.9% | +5.5% | -11.9% | +37.0% | |
| Quarterly EBITDA | $555.00M | +9.5% | +24.2% | -29.0% | +60.5% | |
| TTM EBITDA | $2.22B | +12.3% | +18.6% | -25.0% | +43.1% | |
| Price | $187.94 | +9.0% | +43.8% | +38.8% | +227.4% | |
| PE Ratio | 20.73 | -4.9% | +7.3% | +101.5% | +2.2% | |
| Annual Revenue | $11.04B | +11.8% | +11.7% | +16.9% | +49.8% | |
| Annual EPS | $8.74 | +14.1% | +9.5% | -16.9% | +115.9% | |
| $1.60B | +13.3% | -1.2% | -23.9% | +20.4% | ||
| Annual Net Income | $1.04B | +13.8% | +3.1% | -30.2% | +37.9% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $2.17B | at high | |
| 5Y | $2.85B | -23.8% | |
| All | $2.85B | -23.8% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.79B | +21.4% | |
| 5Y | $1.79B | +21.4% | |
| All | $157.95M | +1275.7% |
EBITDA History
FAQ
What is the current annual EBITDA of DGX?
As of today, DGX annual EBITDA is $2.17B
What is 1-year change in DGX annual EBITDA?
DGX annual EBITDA is up +13.89% year-over-year
What is 3-year change in DGX annual EBITDA?
DGX annual EBITDA is up +5.54% over the past 3 years
How far is DGX annual EBITDA from its all-time high?
DGX annual EBITDA is currently -23.81% below its historical high of $2.85B set on December 31, 2021
How does DGX annual EBITDA rank versus sector peers?
DGX annual EBITDA is higher than 95.62% of companies in Healthcare sector
When is DGX next annual earnings release?
As of today, the next annual earnings release for DGX has not been scheduled
Quarterly EBITDA
$555.00M$19.00M+3.54%
Summary
- Current Value
- As of today, DGX quarterly EBITDA is $555.00M, up +3.54% on
- Historical Performance
- DGX quarterly EBITDA is up +9.47% year-over-year, up +24.16% over the past 3 years
- All-Time High Comparison
- DGX quarterly EBITDA is currently -40.32% below its historical high of $930.00M set on
- 3-Year Low Comparison
- DGX quarterly EBITDA is +32.14% above its 3-year low of $420.00M reached on
- Sector Comparison
- DGX quarterly EBITDA is higher than 95.24% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $555.00M | +3.5% | +9.5% | +24.2% | -29.0% | |
| Annual EBITDA | $2.17B | – | +13.9% | +5.5% | -11.9% | |
| TTM EBITDA | $2.22B | +2.2% | +12.3% | +18.6% | -25.0% | |
| Price | $187.94 | -9.2% | +9.0% | +43.8% | +38.8% | |
| PE Ratio | 20.73 | -12.2% | -4.9% | +7.3% | +101.5% | |
| Quarterly Revenue | $2.90B | +3.2% | +9.2% | +24.2% | +6.4% | |
| Quarterly EPS | $2.24 | +2.5% | +15.6% | +26.0% | -35.4% | |
| $408.00M | +4.3% | +11.2% | +20.0% | -40.1% | ||
| Quarterly Net Income | $263.00M | +2.7% | +12.4% | +21.8% | -46.2% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $568.00M | -2.3% | |
| 3Y | $568.00M | -2.3% | |
| 5Y | $782.00M | N/A | -29.0% |
| All | $930.00M | -40.3% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $507.00M | N/A | +9.5% |
| 3Y | $420.00M | +32.1% | |
| 5Y | $407.00M | +36.4% | |
| All | $27.70M | +1903.6% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of DGX?
As of today, DGX quarterly EBITDA is $555.00M
What is DGX quarterly EBITDA most recent change?
DGX quarterly EBITDA was up +3.54% on March 31, 2026
What is 1-year change in DGX quarterly EBITDA?
DGX quarterly EBITDA is up +9.47% year-over-year
How far is DGX quarterly EBITDA from its all-time high?
DGX quarterly EBITDA is currently -40.32% below its historical high of $930.00M set on December 31, 2020
How does DGX quarterly EBITDA rank versus sector peers?
DGX quarterly EBITDA is higher than 95.24% of companies in Healthcare sector
When is DGX next earnings release?
The next earnings release for DGX is on
TTM EBITDA
$2.22B$48.00M+2.21%
Summary
- Current Value
- As of today, DGX TTM EBITDA is $2.22B, up +2.21% on
- Historical Performance
- DGX TTM EBITDA is up +12.29% year-over-year, up +18.58% over the past 3 years
- All-Time High Comparison
- DGX TTM EBITDA is currently -31.81% below its historical high of $3.26B set on
- 3-Year Low Comparison
- DGX TTM EBITDA is +23.94% above its 3-year low of $1.79B reached on
- Sector Comparison
- DGX TTM EBITDA is higher than 95.43% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $2.22B | +2.2% | +12.3% | +18.6% | -25.0% | |
| Annual EBITDA | $2.17B | – | +13.9% | +5.5% | -11.9% | |
| Quarterly EBITDA | $555.00M | +3.5% | +9.5% | +24.2% | -29.0% | |
| Price | $187.94 | -9.2% | +9.0% | +43.8% | +38.8% | |
| PE Ratio | 20.73 | -12.2% | -4.9% | +7.3% | +101.5% | |
| TTM Revenue | $11.28B | +2.2% | +11.0% | +17.4% | +9.1% | |
| TTM EPS | $9.07 | +3.5% | +14.6% | +34.0% | -31.1% | |
| $1.64B | +2.6% | +12.5% | +14.6% | -36.4% | ||
| TTM Net Income | $1.07B | +2.8% | +13.6% | +25.3% | -42.9% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $2.22B | at high | |
| 3Y | $2.22B | at high | |
| 5Y | $3.26B | -31.8% | |
| All | $3.26B | -31.8% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.98B | N/A | +12.3% |
| 3Y | $1.79B | +23.9% | |
| 5Y | $1.79B | +23.9% | |
| All | $38.40M | +5683.9% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of DGX?
As of today, DGX TTM EBITDA is $2.22B
What is DGX TTM EBITDA most recent change?
DGX TTM EBITDA was up +2.21% on March 31, 2026
What is 1-year change in DGX TTM EBITDA?
DGX TTM EBITDA is up +12.29% year-over-year
How far is DGX TTM EBITDA from its all-time high?
DGX TTM EBITDA is currently -31.81% below its historical high of $3.26B set on June 30, 2021
How does DGX TTM EBITDA rank versus sector peers?
DGX TTM EBITDA is higher than 95.43% of companies in Healthcare sector
When is DGX next earnings release?
The next earnings release for DGX is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- DGX Official Website www.questdiagnostics.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1022079/000102207926000005/0001022079-26-000005-index.htm
- DGX Profile on Yahoo Finance finance.yahoo.com/quote/DGX
- DGX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dgx